BIG Breast International Group
We will find a cure for breast cancer through global research and collaboration.

BIG 1-010 SOLD

The Synergism Or Long Duration (SOLD) Study is a randomized phase III study comparing trastuzumab plus docetaxel (HT) followed by 5-FU, epirubicin, and cyclophosphamide (FEC) to the same regimen.

Coordinating group: Finnish Breast Cancer Group (FBCG)

Target nr. of patients: 3000

ClinicalTrials.gov Identifier: NCT00593697




Scroll to top

Contact us

Breast International Group (BIG)-aisbl Blvd de Waterloo 121 B-1000 Brussels | Belgium VAT BE 0468 176 240